Dopamine dysfunction in stimulant use disorders: mechanistic comparisons and implications for treatment. Kohno, M., Dennis, L. E., McCready, H., & Hoffman, W. F. Molecular Psychiatry, 27(1):220–229, January, 2022. Number: 1 Publisher: Nature Publishing Group![Dopamine dysfunction in stimulant use disorders: mechanistic comparisons and implications for treatment [link]](https://bibbase.org/img/filetypes/link.svg "link")
Paper doi abstract bibtex Dopamine system deficiencies and associated behavioral phenotypes may be a critical barrier to success in treating stimulant use disorders. Similarities in dopamine dysfunction between cocaine and methamphetamine use disorder but also key differences may impact treatment efficacy and outcome. This review will first compare the epidemiology of cocaine and methamphetamine use disorder. A detailed account of the pharmacokinetic and pharmacodynamic properties associated with each drug will then be discussed, with an emphasis on effects on the dopamine system and associated signaling pathways. Lastly, treatment results from pharmacological clinical trials will be summarized along with a more comprehensive review of the involvement of the trace amine-associated receptor on dopamine signaling dysfunction among stimulants and its potential as a therapeutic target.
@article{kohno_dopamine_2022,
title = {Dopamine dysfunction in stimulant use disorders: mechanistic comparisons and implications for treatment},
volume = {27},
copyright = {2021 This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply},
issn = {1476-5578},
shorttitle = {Dopamine dysfunction in stimulant use disorders},
url = {https://www.nature.com/articles/s41380-021-01180-4},
doi = {10.1038/s41380-021-01180-4},
abstract = {Dopamine system deficiencies and associated behavioral phenotypes may be a critical barrier to success in treating stimulant use disorders. Similarities in dopamine dysfunction between cocaine and methamphetamine use disorder but also key differences may impact treatment efficacy and outcome. This review will first compare the epidemiology of cocaine and methamphetamine use disorder. A detailed account of the pharmacokinetic and pharmacodynamic properties associated with each drug will then be discussed, with an emphasis on effects on the dopamine system and associated signaling pathways. Lastly, treatment results from pharmacological clinical trials will be summarized along with a more comprehensive review of the involvement of the trace amine-associated receptor on dopamine signaling dysfunction among stimulants and its potential as a therapeutic target.},
language = {en},
number = {1},
urldate = {2023-05-30},
journal = {Molecular Psychiatry},
author = {Kohno, Milky and Dennis, Laura E. and McCready, Holly and Hoffman, William F.},
month = jan,
year = {2022},
note = {Number: 1
Publisher: Nature Publishing Group},
keywords = {Addiction, Biomarkers, Neuroscience},
pages = {220--229},
}
Downloads: 0
{"_id":"toYdFLQfCysJZuCAY","bibbaseid":"kohno-dennis-mccready-hoffman-dopaminedysfunctioninstimulantusedisordersmechanisticcomparisonsandimplicationsfortreatment-2022","author_short":["Kohno, M.","Dennis, L. E.","McCready, H.","Hoffman, W. F."],"bibdata":{"bibtype":"article","type":"article","title":"Dopamine dysfunction in stimulant use disorders: mechanistic comparisons and implications for treatment","volume":"27","copyright":"2021 This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply","issn":"1476-5578","shorttitle":"Dopamine dysfunction in stimulant use disorders","url":"https://www.nature.com/articles/s41380-021-01180-4","doi":"10.1038/s41380-021-01180-4","abstract":"Dopamine system deficiencies and associated behavioral phenotypes may be a critical barrier to success in treating stimulant use disorders. Similarities in dopamine dysfunction between cocaine and methamphetamine use disorder but also key differences may impact treatment efficacy and outcome. This review will first compare the epidemiology of cocaine and methamphetamine use disorder. A detailed account of the pharmacokinetic and pharmacodynamic properties associated with each drug will then be discussed, with an emphasis on effects on the dopamine system and associated signaling pathways. Lastly, treatment results from pharmacological clinical trials will be summarized along with a more comprehensive review of the involvement of the trace amine-associated receptor on dopamine signaling dysfunction among stimulants and its potential as a therapeutic target.","language":"en","number":"1","urldate":"2023-05-30","journal":"Molecular Psychiatry","author":[{"propositions":[],"lastnames":["Kohno"],"firstnames":["Milky"],"suffixes":[]},{"propositions":[],"lastnames":["Dennis"],"firstnames":["Laura","E."],"suffixes":[]},{"propositions":[],"lastnames":["McCready"],"firstnames":["Holly"],"suffixes":[]},{"propositions":[],"lastnames":["Hoffman"],"firstnames":["William","F."],"suffixes":[]}],"month":"January","year":"2022","note":"Number: 1 Publisher: Nature Publishing Group","keywords":"Addiction, Biomarkers, Neuroscience","pages":"220–229","bibtex":"@article{kohno_dopamine_2022,\n\ttitle = {Dopamine dysfunction in stimulant use disorders: mechanistic comparisons and implications for treatment},\n\tvolume = {27},\n\tcopyright = {2021 This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply},\n\tissn = {1476-5578},\n\tshorttitle = {Dopamine dysfunction in stimulant use disorders},\n\turl = {https://www.nature.com/articles/s41380-021-01180-4},\n\tdoi = {10.1038/s41380-021-01180-4},\n\tabstract = {Dopamine system deficiencies and associated behavioral phenotypes may be a critical barrier to success in treating stimulant use disorders. Similarities in dopamine dysfunction between cocaine and methamphetamine use disorder but also key differences may impact treatment efficacy and outcome. This review will first compare the epidemiology of cocaine and methamphetamine use disorder. A detailed account of the pharmacokinetic and pharmacodynamic properties associated with each drug will then be discussed, with an emphasis on effects on the dopamine system and associated signaling pathways. Lastly, treatment results from pharmacological clinical trials will be summarized along with a more comprehensive review of the involvement of the trace amine-associated receptor on dopamine signaling dysfunction among stimulants and its potential as a therapeutic target.},\n\tlanguage = {en},\n\tnumber = {1},\n\turldate = {2023-05-30},\n\tjournal = {Molecular Psychiatry},\n\tauthor = {Kohno, Milky and Dennis, Laura E. and McCready, Holly and Hoffman, William F.},\n\tmonth = jan,\n\tyear = {2022},\n\tnote = {Number: 1\nPublisher: Nature Publishing Group},\n\tkeywords = {Addiction, Biomarkers, Neuroscience},\n\tpages = {220--229},\n}\n\n","author_short":["Kohno, M.","Dennis, L. E.","McCready, H.","Hoffman, W. F."],"key":"kohno_dopamine_2022","id":"kohno_dopamine_2022","bibbaseid":"kohno-dennis-mccready-hoffman-dopaminedysfunctioninstimulantusedisordersmechanisticcomparisonsandimplicationsfortreatment-2022","role":"author","urls":{"Paper":"https://www.nature.com/articles/s41380-021-01180-4"},"keyword":["Addiction","Biomarkers","Neuroscience"],"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/tub49573","dataSources":["zdB47AZpEkG3LzPTn"],"keywords":["addiction","biomarkers","neuroscience"],"search_terms":["dopamine","dysfunction","stimulant","use","disorders","mechanistic","comparisons","implications","treatment","kohno","dennis","mccready","hoffman"],"title":"Dopamine dysfunction in stimulant use disorders: mechanistic comparisons and implications for treatment","year":2022}